"Apbot" Lipolytic enzyme test set of correction solution and quality control solution - Taiwan Registration 146a74b20dc1710c52022954b407fd0b
Access comprehensive regulatory information for "Apbot" Lipolytic enzyme test set of correction solution and quality control solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 146a74b20dc1710c52022954b407fd0b and manufactured by SENTINEL CH. S.p.A.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Correction solution: This product can only be used to correct lipase NG. In vitro diagnostic use. Pipe solution 1, 2: This product can only be used to verify the performance of lipase NG.
A Clinical chemistry and clinical toxicology
A.1150 calibration;; A.1660 Quality control materials (analytical and non-analytical)
import
Dates and Status
Jan 08, 2020
Jan 08, 2030